Ivan Jambor
ivjamb@utu.fi |
- Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancerLow-Field Portable Magnetic Resonance Imaging for Post-Thrombectomy Assessment of Ongoing Brain Injury (2025)
- European Journal of Nuclear Medicine and Molecular ImagingStroke : vascular and interventional neurologyEuropean Radiology
- Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate CancerProstate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth (2024)
- European Urology Open ScienceMedical Physics
- Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2024)
- Journal of Magnetic Resonance Imaging
- Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study (2024)
- PLoS ONE
- Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors (2023)
- World Journal of UrologyEuropean Urology Oncology
- Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2023)
- Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score (2023)
- Reply by AuthorsQuicksort leave-pair-out cross-validation for ROC curve analysis (2023)
- Journal of Urology
- Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma (2023)
- Journal of Urology
- Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2023)
- Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer (2022)
- Cancers
- Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer (2022)
- Nuclear Medicine CommunicationsComputational Statistics
- Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate CancerThe Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator (2022)
- Journal of Magnetic Resonance ImagingEuropean Urology Open Science
- Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging FindingsWhen to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level (2022
- (2022)
- BMJ Open
- (2022)
- European Urology
- (2022)
- (2022)
- (2022)
- World Journal of Urology
- Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)
- International Journal of Radiation Oncology - Biology - Physics